Announcement on Voluntary Disclosure of Ganciclovir for Injection Passing Consistency Evaluation of Quality and Efficacy of Generic Drugs

About this update from Youcare Pharmaceutical Group Co. Ltd. Class A

Announcement on Voluntary Disclosure of Ganciclovir for Injection Passing Consistency Evaluation of Quality and Efficacy of Generic DrugsThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Youcare Pharmaceutical Group Co. Ltd. Class A